Novel Recombinant Protein UK114 in Stable Polymer Form for Tumour Treatment

Thu, 16 Apr 2026 08:37:38 +0000
Intellectual Property

The European Patent Office granted Patent EP3554639A1 to Alberto Bartorelli Cusani for a novel recombinant protein UK114 in stable polymer form designed for the treatment or prevention of malignant solid and systemic tumours. The patent covers pharmaceutical compositions containing the recombinant protein and methods of treatment. The patent is classified under A61K 38/50 and related pharmaceutical categories.